Atul B Mehta - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Atul B Mehta

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Haematologica|February 12, 2002

Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitroKanagasabai Ganeshaguru, Ranmohan G Wickremasinghe, Dylan T Jones, et al.

Orphanet Journal of Rare Diseases|June 20, 2022

Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registryMichael Beck, Uma Ramaswami, Elizabeth Hernberg-Ståhl, et al.

Molecular Genetics and Metabolism|December 3, 2009

A validated disease severity scoring system for Fabry diseaseEdward H Giannini, Atul B Mehta, Max J Hilz, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Haematologica|February 12, 2002

Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitroKanagasabai Ganeshaguru, Ranmohan G Wickremasinghe, Dylan T Jones, et al.

Orphanet Journal of Rare Diseases|June 20, 2022

Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registryMichael Beck, Uma Ramaswami, Elizabeth Hernberg-Ståhl, et al.

Molecular Genetics and Metabolism|December 3, 2009

A validated disease severity scoring system for Fabry diseaseEdward H Giannini, Atul B Mehta, Max J Hilz, et al.

Pageof 3